Imaging of pancreatic islet cells

Research output: Contribution to journalArticle

Abstract

At present, the onset and progress of diabetes, and the efficacy of potential treatments, can only be assessed through indirect means, i.e. blood glucose, insulin, or C-peptide measurements. The development of non-invasive and reliable methods for (1) quantification of pancreatic beta islet cell mass in vivo, (2) determining endogenous islet function and survival, and (3) visualizing the biodistribution, survival, and function of transplanted exogenous islets are critical to further advance both basic science research and islet cell therapy in diabetes. Islet cell imaging using magnetic resonance, bioluminescence, positron emission tomography, or single photon emission computed tomography may provide us with a direct means to interrogate islet cell distribution, survival, and function. Current state-of-the-art strategies for beta-cell imaging are discussed and reviewed here in context of their clinical relevance.

Original languageEnglish (US)
Pages (from-to)761-766
Number of pages6
JournalDiabetes/Metabolism Research and Reviews
Volume27
Issue number8
DOIs
StatePublished - Nov 2011

Fingerprint

Islets of Langerhans
C-Peptide
Insulin-Secreting Cells
Cell- and Tissue-Based Therapy
Single-Photon Emission-Computed Tomography
Positron-Emission Tomography
Blood Glucose
Cell Survival
Magnetic Resonance Imaging
Insulin
Research

Keywords

  • Bioluminescent imaging
  • Diabetes
  • Islets
  • Magnetic resonance imaging
  • Positron emission tomography
  • Transplantation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Imaging of pancreatic islet cells. / Arifin, Dian; Bulte, Jeff W.

In: Diabetes/Metabolism Research and Reviews, Vol. 27, No. 8, 11.2011, p. 761-766.

Research output: Contribution to journalArticle

@article{cd833da39f4c43dab928ee0f059a4951,
title = "Imaging of pancreatic islet cells",
abstract = "At present, the onset and progress of diabetes, and the efficacy of potential treatments, can only be assessed through indirect means, i.e. blood glucose, insulin, or C-peptide measurements. The development of non-invasive and reliable methods for (1) quantification of pancreatic beta islet cell mass in vivo, (2) determining endogenous islet function and survival, and (3) visualizing the biodistribution, survival, and function of transplanted exogenous islets are critical to further advance both basic science research and islet cell therapy in diabetes. Islet cell imaging using magnetic resonance, bioluminescence, positron emission tomography, or single photon emission computed tomography may provide us with a direct means to interrogate islet cell distribution, survival, and function. Current state-of-the-art strategies for beta-cell imaging are discussed and reviewed here in context of their clinical relevance.",
keywords = "Bioluminescent imaging, Diabetes, Islets, Magnetic resonance imaging, Positron emission tomography, Transplantation",
author = "Dian Arifin and Bulte, {Jeff W}",
year = "2011",
month = "11",
doi = "10.1002/dmrr.1248",
language = "English (US)",
volume = "27",
pages = "761--766",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Imaging of pancreatic islet cells

AU - Arifin, Dian

AU - Bulte, Jeff W

PY - 2011/11

Y1 - 2011/11

N2 - At present, the onset and progress of diabetes, and the efficacy of potential treatments, can only be assessed through indirect means, i.e. blood glucose, insulin, or C-peptide measurements. The development of non-invasive and reliable methods for (1) quantification of pancreatic beta islet cell mass in vivo, (2) determining endogenous islet function and survival, and (3) visualizing the biodistribution, survival, and function of transplanted exogenous islets are critical to further advance both basic science research and islet cell therapy in diabetes. Islet cell imaging using magnetic resonance, bioluminescence, positron emission tomography, or single photon emission computed tomography may provide us with a direct means to interrogate islet cell distribution, survival, and function. Current state-of-the-art strategies for beta-cell imaging are discussed and reviewed here in context of their clinical relevance.

AB - At present, the onset and progress of diabetes, and the efficacy of potential treatments, can only be assessed through indirect means, i.e. blood glucose, insulin, or C-peptide measurements. The development of non-invasive and reliable methods for (1) quantification of pancreatic beta islet cell mass in vivo, (2) determining endogenous islet function and survival, and (3) visualizing the biodistribution, survival, and function of transplanted exogenous islets are critical to further advance both basic science research and islet cell therapy in diabetes. Islet cell imaging using magnetic resonance, bioluminescence, positron emission tomography, or single photon emission computed tomography may provide us with a direct means to interrogate islet cell distribution, survival, and function. Current state-of-the-art strategies for beta-cell imaging are discussed and reviewed here in context of their clinical relevance.

KW - Bioluminescent imaging

KW - Diabetes

KW - Islets

KW - Magnetic resonance imaging

KW - Positron emission tomography

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=80855147978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855147978&partnerID=8YFLogxK

U2 - 10.1002/dmrr.1248

DO - 10.1002/dmrr.1248

M3 - Article

C2 - 22069256

AN - SCOPUS:80855147978

VL - 27

SP - 761

EP - 766

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 8

ER -